If Omapro is never commercialised then, sure, Chemgenex's current valuation won't be realised. But I thought we were debating the size and value of the market assuming successful commercialisation.
Assuming commercialisation, the European rights (subject to a royalty to Chemgenex) are worth $140 million, at least to Hospira.
omapro addressable market size, page-8
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)